Journal ArticleOPEN ACCESS

Treatment of cytokine storm syndrome with IL-1 receptor antagonist anakinra in a patient with ARDS caused by COVID-19 infection: A case report

Clinical Case Reports (2020) 8(12) 2990-2994
DOI: 10.1002/ccr3.3307
4Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The biological anakinra appears promising to halt cytokine storm syndrome seen in severe courses of COVID-19. However, immunosuppression with anakinra may facilitate sepsis, necessitating continuous screening for bacterial superinfections.

Cite

CITATION STYLE

APA

Kaps, L., Labenz, C., Grimm, D., Schwarting, A., Galle, P. R., & Schreiner, O. (2020). Treatment of cytokine storm syndrome with IL-1 receptor antagonist anakinra in a patient with ARDS caused by COVID-19 infection: A case report. Clinical Case Reports, 8(12), 2990–2994. https://doi.org/10.1002/ccr3.3307

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free